ARTICLE | Clinical News
Ampion: Preliminary Ph I data
December 2, 2016 7:33 PM UTC
Preliminary data from the double-blind, placebo-controlled, U.S. Phase I AP-011 trial in 15 patients showed that a single intra-articular injection of up to 3 mL Ampion was well tolerated with no seri...
BCIQ Company Profiles